Evidence from the engineered expression of CXCL10 in isogenic rectal CT26 cancer cells suggests that they provide a protective and anti-metastatic role, mediated mainly by adaptive immunity of tumor-infiltrating T cells [78]. Here, CXCL10 is linked to neoplasm.